Manufacturing-associated carbon footprints vary across novel systemic therapies for atopic dermatitis
Journal of the American Academy of Dermatology · 2026-09
DOI: 10.1016/j.jaad.2026.09.048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-09. Verfasst von Alondra Soto-González und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Universidad Central del Caribe …. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Health care produces ∼5% of global greenhouse gas emissions, with pharmaceuticals among the largest sources in dermatology.1 Climate change can worsen atopic dermatitis (AD), making the environmental impact of AD therapies relevant to population health.2 AD affects 16.5 million US adults, 40% of whom have moderate-to-severe disease requiring systemic therapy.3 However, manufacturing carbon footprints of novel systemic AD therapies have not been compared.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Universidad Central del Caribe School of Medicine, Bayamón, Puerto Rico. Electronic address: sotogona…
- Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania; Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
- Department of Dermatology and Center for Biomedical Ethics and Society, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Zitieren
APA
Soto-González, A., Chu, E. W., Parker, E. R., Rosenbach, M., & Chiesa Fuxench, Z. C. (2026). Manufacturing-associated carbon footprints vary across novel systemic therapies for atopic dermatitis. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.048
Vancouver
Soto-González A, Chu EW, Parker ER, Rosenbach M, Chiesa Fuxench ZC. Manufacturing-associated carbon footprints vary across novel systemic therapies for atopic dermatitis. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.09.048
BibTeX
@article{SotoGonzlez2026,
author = {Soto-González, Alondra and Chu, Emily W and Parker, Eva Rawlings and Rosenbach, Misha and Chiesa Fuxench, Zelma C},
title = {Manufacturing-associated carbon footprints vary across novel systemic therapies for atopic dermatitis},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.09.048}
}
EUVIMED